With reference to the captioned subject matter, pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018, we hereby submit the certificate received from M/s R&D Infotech Private Limited, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has submitted a quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended September 30, 2025. The certificate was issued by the company's Registrar and Transfer Agent (RTA), M/s. R&D Infotech Private Limited. It confirms that all share dematerialisation requests received from depository participants during the quarter were processed and confirmed (accepted or rejected) to the depositories. It also confirms that physical share certificates received for demat have been cancelled after verification, and the depository's name has been substituted as the registered owner in the company's records within the 15-day timeline. This is a routine procedural filing required every quarter, with no change in the company's financials or operations.
This is a standard regulatory compliance filing with no material impact on the business, financials, or share price. Investors can take it as a sign of regular compliance with SEBI's depository rules, but it carries no investment signal.